Novo Nordisk A/SEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 338.05 DKK | 396,282 DKK | 216,774 DKK |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - DKK | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 3.347.023.520 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Novo Nordisk A/S
Mitarbeiter 67.900
Handelsplatz CO
Ticker Symbol NOVO-B
IPO Datum -
Adresse Novo Alle 1, Bagsvaerd, Denmark, 2880
Webseite https://www.novonordisk.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Karsten Munk Knudsen | Executive VP, CFO & Member of the Management Board |
| 2 | Mr. Maziar Mike Doustdar B.A. | President, CEO & Member of the Management Board |
| 3 | Dr. Martin Holst Lange | EVP of R&D, Chief Scientific Officer and Member of the Management Board |
| 4 | Ms. Tania Sabroe | EVP of People, Organisation and Corporate Affairs & Member of Management Board |
| 5 | Ms. Thilde Hummel Bogebjerg | Executive VP of Enterprise IT & Quality and Member of Management Board |
| 6 | Mr. John F. Kuckelman | SVP, Group General Counsel, Global Legal, IP & Security and Member of Management Board |
| 7 | Mr. Emil Kongshoej Larsen | EVP of International Operations & Member of Management Board |
| 8 | Ms. Elin Jager | SVP, Chief of Staff to CEO, Corporate Strategy & Sustainability and Member of Management Board |
| 9 | Mr. Jamey Millar | Executive VP of US Operations & Member of Management Board |
| 10 | Ms. Hong Chow | Executive VP of Product & Portfolio Strategy and Member of Management Board |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.